GATA2

Clinical trials for GATA2 explained in plain language.

Never miss a new study

Get alerted when new GATA2 trials appear

Sign up with your email to follow new studies for GATA2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New hope for safer cure of devastating immune disorder

Disease control Ongoing

This study is testing if a new drug called Briquilimab can make stem cell transplants safer for people with GATA2 deficiency, a genetic disorder that weakens the immune system and can lead to blood cancers. Participants receive Briquilimab as part of their preparation for a trans…

Matched conditions: GATA2

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:42 UTC

GATA2

Get alerted when new GATA2 trials appear

New hope for safer cure of devastating immune disorder